Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acids encoding interleukin-12P40 variants with improved stability

Nucleic acids encoding interleukin-12P40 variants with improved stability

US Patent 8188248 · Granted May 29, 2012

Estimated economic value: $53,466,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted TGFβ inhibition2022
Anti-CD19 antibodies with reduced immunogenicity2021
SIRP-α immunoglobulin fusion proteins2021
Methods of use of anti-CD19 antibodies with reduced immunogenicity2018
Targeted TGFβ inhibitors2017
Methods of treating cancer using interleukin-12p40 variants having improved stab2015
Methods of treating cancer using interleukin-12p40 variants having improved stab2015
Methods of treating cancer using interleukin-12p40 variants having improved stab2015
Methods of treating cancer using interleukin-12p40 variants having improved stab2015
Anti-CD19 antibodies with reduced immunogenicity2015
Antibody fusion proteins with a modified FcRn binding site2014
Antibody fusion proteins with a modified FcRn binding site2014